CytomX Therapeutics, Inc. (CTMX)
NASDAQ·Healthcare·Biotechnology
$3.21
-0.47%
Mkt Cap $535.54M
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (21 analysts)
$11.50
Range $10.00 – $16.00
Implied Upside
+258.8%
Consensus $11.50 vs current $3.21
NASDAQ·Healthcare·Biotechnology
$3.21
-0.47%
Mkt Cap $535.54M
Buy
11
Hold
0
Sell
0
Price Target (21 analysts)
$11.50
Range $10.00 – $16.00
+258.8%
Consensus $11.50 vs current $3.21